Thermo Fisher Scientific (NY:TMO)

684.89 +11.07 (+1.64%)

Official Closing Price Updated: 7:00 PM EDT, Oct 26, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Thermo Fisher Scientific

< Previous 1 2

...

29 30 31 32 33 34 35 36 Next >

Thermo Fisher's COVID-19 Response Revenue Accounts For 22% In Q3 Sales, Boosts FY21 Outlook ↗

October 27, 2021

Thermo Fisher Scientific Inc (NYSE: TMO) has posted Q3 revenues of $9.33 billion, up 9% Y/Y, beating the consensus of $8.39 billion. Organic revenue growth from...

Via Benzinga

Thermo Fisher Scientific: Q3 Earnings Insights ↗

October 27, 2021

Thermo Fisher Scientific (NYSE:TMO) reported its Q3 earnings results on Wednesday, October 27, 2021 at 06:00 AM. Here's what investors need to know about the...

Via Benzinga

Earnings Scheduled For October 27, 2021 ↗

October 27, 2021

Companies Reporting Before The Bell • McDonald's (NYSE:MCD) is expected to report quarterly earnings at $2.46 per share on revenue of $6.03 billion. • General...

Via Benzinga

Tuesday Market Coverage ↗

October 26, 2021

Thermo Electron fell on the publication of its social responsibility report today.

Via Talk Markets

Wednesday Market Coverage ↗

October 20, 2021

Today gold rose again despite the active market for bitcoin and the lower Chinese demand for mine products like iron and coal.

Via Talk Markets

TMO Stock Forecast: The World Leader In Serving Science ↗

October 18, 2021

TMO is a strong buy stock, it is a stable and powerful technology stock with good management and a strong financial position, which is reasonable for long-term holding.

Via Talk Markets

The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More ↗

October 24, 2021

Biotech stocks posted gains for the second week running, supported by multiple catalysts that included a good start to the big pharma reporting season and broader market strength...

Via Benzinga

Where Thermo Fisher Scientific Stands With Analysts ↗

October 20, 2021

Thermo Fisher Scientific (NYSE:TMO) has observed the following analyst rating...

Via Benzinga

Chinese Growth Level ↗

October 18, 2021

The hot news today was a much weaker Chinese growth level this year, of 4.9% because of supply chain issues.

Via Talk Markets

Benzinga's Top Ratings Upgrades, Downgrades For October 20, 2021 ↗

October 20, 2021

Upgrades For Iridium Communications Inc (NASDAQ:IRD...

Via Benzinga

3 Dividend Stocks That Hiked Their Payouts by More Than 10% This Year ↗

October 15, 2021

And more rate hikes are likely in their future.

Via The Motley Fool

Friday Market Coverage ↗

October 08, 2021

New hiring again failed to rise in Sept., the 2nd month in a row which may be good news because it could delay the Fed tapering.

Via Talk Markets

Topics Economy

Semiconductor Shortage Hits Supply Chain For MedTech Industry ↗

September 24, 2021

According to a study commissioned by AdvaMed, the global semiconductor chip shortage is causing delays, order cancellations, and other supply disruptions at MedTech companies....

Via Benzinga

FDA Establishes Additional Conditions Of Emergency Use Nod For COVID-19 Tests For Viral Mutations ↗

September 24, 2021

The FDA has issued a letter to establish additional conditions of Emergency Use Authorizations (EUAs) manufacturers of COVID-19 tests. The agency has asked COVID-19...

Via Benzinga

'Fast Money Halftime Report' Picks For September 23 ↗

September 23, 2021

On CNBC's "Fast Money Halftime Report," Karen Firestone said Thermo Fisher Scientific Inc. (NYSE: TMO) had a great analyst day. It raised guidance for 2022 and the...

Via Benzinga

Expert Ratings For Thermo Fisher Scientific ↗

September 23, 2021

Thermo Fisher Scientific (NYSE:TMO) has observed the following analyst rating...

Via Benzinga

10 Biggest Price Target Changes For Wednesday ↗

September 22, 2021

Piper Sandler boosted the price target for Adobe Inc. (NASDAQ: ADBE) from $600 to $670. Adobe shares fell 3.5% to $623.50 in pre-market trading. Keybanc reduced the price target...

Via Benzinga

A Day Of Huge Market Moves ↗

September 21, 2021

It was a day of huge market moves and several reporting companies. Trudeau won but did not get a parliamentary majority.

Via Talk Markets

Pharma, Tech and Finance ↗

September 20, 2021

Good news on some drugs was not enough to boost stock markets.

Via Talk Markets

Analyst Ratings For Thermo Fisher Scientific ↗

September 20, 2021

Within the last quarter, Thermo Fisher Scientific (NYSE:TMO) has observed the...

Via Benzinga

10 Biggest Price Target Changes For Monday ↗

September 20, 2021

Barclays boosted Upstart Holdings, Inc. (NASDAQ:UPST

Via Benzinga

48 Biggest Movers From Friday ↗

September 20, 2021

Gainers Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS) shares jumped 135.4% to settle at $5.32 on Friday. The stock possibly traded higher following favorable data results by...

Via Benzinga

Why Thermo Fisher Shares Are Trading Higher Today ↗

September 17, 2021

Thermo Fisher Scientific Inc (NYSE: TMO) is trading higher Friday after the company issued full-year 2022 financial guidance above analyst estimates. Thermo Fisher...

Via Benzinga

Thermo Fisher Called For A Covid Testing Dive, And Soared — Here's Why ↗

September 17, 2021

Thermo Fisher Scientific crushed guidance expectations for 2022 and beyond on Friday, and TMO stock surged to a fresh high.

Via Investor's Business Daily

Investor React Positively To Thermo Fisher's Annual Guidance ↗

September 17, 2021

Thermo Fisher Scientific Inc (NYSE: TMO) provided initial revenue and earnings guidance for 2022 while reiterating previously disclosed financial guidance for full...

Via Benzinga

Takeda's Exkivity Scores FDA Nod As First Oral Therapy For Lung Cancer With EGFR Exon20 Insertion ↗

September 16, 2021

The FDA has approved Takeda Pharmaceutical Co Ltd's (NYSE: TAK) Exkivity (mobocertinib) for non-small cell lung cancer (NSCLC) settings. The approval comes for...

Via Benzinga

Post-Rosh Hashanah, Sell? ↗

September 08, 2021

As the saying goes, sell Rosh Hashanah and buy Yom Kippur. Does it apply this year?

Via Talk Markets

The Daily Biotech Pulse: Leap, Phio, Silverback Among Early Movers On Oncology Conference Presentations, Aerie Slumps On Mixed Data, Axsome Commences Phase 3 Sleep Disorder Study ↗

September 16, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 15) Alcon Inc. (NYSE: ALC)...

Via Benzinga

The Daily Biotech Pulse: Apellis Sinks On Data, Endo Shines On Opioid Litigation Settlement, T2 Biosystems Soars On Mutant Detection Ability of COVID Test ↗

September 10, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 9) Adagio Therapeutics, Inc. (...

Via Benzinga

The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi's Pemphigus Trial Disappointment, Humanigen's COVID-19 Drug Denied Emergency Use Authorization ↗

September 09, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 8) Abbott Laboratories (NYSE:...

Via Benzinga

< Previous 1 2

...

29 30 31 32 33 34 35 36 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.